Lulu Iles-Shih1, Kristen Hilden, Douglas G Adler. 1. Gastroenterology and Hepatology, Huntsman Cancer Center, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Abstract
AIMS: Combined ERCP/EUS is becoming common. Combined procedures are frequently performed in elderly patients. We hypothesized that combined ERCP/EUS is equally safe in elderly patients when compared to non-elderly patients. METHODS: This was a retrospective single-center study comparing outcomes in elderly and non-elderly patients undergoing combined ERCP/EUS. RESULTS: A total of 206 patients were included. Mean age was 65 years (M:F 113:93); 99 were <65 years and 107 were >65. Indications included: jaundice (51%), abnormal imaging (17%), pancreatic tumor (11%), abdominal pain (5%), stent placement/change (5%), acute or chronic pancreatitis (5%), other (6%). Fine needle aspiration was performed in 134 (65%) procedures. Malignancy was identified in 142/206 (69%) patients. Mean Charlson Comorbidity Index (CCI) was 7.5 (range 0-22). Among patients <65 years old there were no immediate adverse events. Long-term adverse events in patients <65 (within 30 days) included cholangitis (1), increasing abdominal pain (4), post-ERCP pancreatitis (3), nausea/vomiting (1), increasing fatigue (1), and increasing jaundice (1). A subgroup analysis among geriatric patients (>65) was performed. Mean CCI was 8.2 (range 0-22). There was one immediate adverse event of non-sustained ventricular tachycardia in a 76-year old. Long-term adverse events included increasing fatigue (1), nausea/vomiting (2), increasing abdominal pain (2), urosepsis (1), fever (2) and dehydration (1). There were no statistically significant differences in outcomes in elderly compared to non-elderly patients. Elderly patients had higher CCI scores (p = 0.04). CONCLUSION: Combined ERCP/EUS in one session is safe in the general population and elderly patients, with no more adverse events than in non-elderly patients.
AIMS: Combined ERCP/EUS is becoming common. Combined procedures are frequently performed in elderly patients. We hypothesized that combined ERCP/EUS is equally safe in elderly patients when compared to non-elderly patients. METHODS: This was a retrospective single-center study comparing outcomes in elderly and non-elderly patients undergoing combined ERCP/EUS. RESULTS: A total of 206 patients were included. Mean age was 65 years (M:F 113:93); 99 were <65 years and 107 were >65. Indications included: jaundice (51%), abnormal imaging (17%), pancreatic tumor (11%), abdominal pain (5%), stent placement/change (5%), acute or chronic pancreatitis (5%), other (6%). Fine needle aspiration was performed in 134 (65%) procedures. Malignancy was identified in 142/206 (69%) patients. Mean Charlson Comorbidity Index (CCI) was 7.5 (range 0-22). Among patients <65 years old there were no immediate adverse events. Long-term adverse events in patients <65 (within 30 days) included cholangitis (1), increasing abdominal pain (4), post-ERCP pancreatitis (3), nausea/vomiting (1), increasing fatigue (1), and increasing jaundice (1). A subgroup analysis among geriatric patients (>65) was performed. Mean CCI was 8.2 (range 0-22). There was one immediate adverse event of non-sustained ventricular tachycardia in a 76-year old. Long-term adverse events included increasing fatigue (1), nausea/vomiting (2), increasing abdominal pain (2), urosepsis (1), fever (2) and dehydration (1). There were no statistically significant differences in outcomes in elderly compared to non-elderly patients. Elderly patients had higher CCI scores (p = 0.04). CONCLUSION: Combined ERCP/EUS in one session is safe in the general population and elderly patients, with no more adverse events than in non-elderly patients.
Authors: Mohamad A Eloubeidi; Frank G Gress; Thomas J Savides; Maurits J Wiersema; Michael L Kochman; Nuzhat A Ahmad; Gregory G Ginsberg; Richard A Erickson; John Dewitt; Jacques Van Dam; Nicholas J Nickl; Michael J Levy; Jonathan E Clain; Amitabh Chak; Michael V Sivak; Richard Wong; Gerard Isenberg; James M Scheiman; Brenna Bounds; Michael B Kimmey; Michael D Saunders; Kenneth J Chang; Ashish Sharma; Phoniex Nguyen; John G Lee; Steven A Edmundowicz; Dayna Early; Riad Azar; Babak Etemad; Yang K Chen; Irving Waxman; Vanessa Shami; Mark F Catalano; C Mel Wilcox Journal: Gastrointest Endosc Date: 2004-09 Impact factor: 9.427
Authors: William A Ross; Sanjeev M Wasan; Douglas B Evans; Robert A Wolff; Leonard V Trapani; Gregg A Staerkel; Thomas Prindiville; Jeffrey H Lee Journal: Gastrointest Endosc Date: 2008-04-02 Impact factor: 9.427
Authors: Jason P Etzel; Sue C Eng; Cynthia W Ko; Scott D Lee; Michael D Saunders; Bruce Y Tung; Michael B Kimmey; Kris V Kowdley Journal: Gastrointest Endosc Date: 2007-12-03 Impact factor: 9.427
Authors: Serge A Sorser; David S Fan; Emily E Tommolino; Roberto M Gamara; Kristen Cox; Ben Chortkoff; Douglas G Adler Journal: Dig Dis Sci Date: 2013-11-08 Impact factor: 3.199